hematologic malignancy

Allogeneic Stem Cell Transplantation After 70: Japanese Registry Data Define Who May Benefit Most

By MedXY 06/19/2026

A Japanese registry study of 929 patients aged 70+ identified six predictors of worse survival after allo-HSCT and created a simple score that sharply stratified 2-year overall survival from 57.1% to 2.5%.

Hematology-Oncology news Oncology

Pre-diagnostic Clonal Hematopoiesis Raises Risk of Second Cancers in Patients With Primary Cancer

By MedXY 06/08/2026

Patients with primary cancer who had pre-diagnostic CHIP faced a higher risk of second cancers, especially blood cancers. The findings suggest CHIP may help identify survivors who need closer long-term monitoring.

Hematology-Oncology news

Navigating the Decision to Transplant Before Cancer Develops: A New Framework for RUNX1 Familial Platelet Disorder

By MedXY 04/12/2026

Researchers present a pioneering preemptive hematopoietic stem cell transplantation approach for RUNX1-FPD, a hereditary disorder carrying a 35-50% lifetime risk of blood cancer, introducing a shared decision-making framework to guide this complex clinical choice.